Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | |
| Pubblicazione: |
Zenodo
2025
|
| Accesso online: | https://doi.org/10.5281/zenodo.16447749 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- <p>LucIDix is a <strong>revolutionary bio-circuit platform</strong> creating <em>self-driving cellular therapeutics</em>. By integrating patented light-free bioluminescence (BRET), CRISPR logic gates, and AI-driven feedback loops, our technology enables real-time disease detection, decision-making, and treatment <em>within living tissues</em>—eliminating external hardware, toxic co-factors, and manual intervention. With <strong>8+ patent families</strong> securing core IP, LucIDix targets a $175B precision medicine market through modular applications in oncology, neurology, and regenerative therapies.</p> <p> </p> <p><em>"A.T.K is Founder/CEO of Lucidix Inc. and holds equity. All patents are assigned to Lucidix Inc."</em></p> <p> </p> <p> </p>